The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Living your best life is still possible ... The landscape of early-onset Alzheimer’s treatment is changing rapidly, with more options becoming available. Both Jonel and Missie discovered ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec ... such as figuring out a taxi route or the best way to navigate to a hospital -- could lead to lower ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

The pathology of Alzheimer’s disease was identified in 1906. We remain with neither cure nor treatments that reverse symptoms or stop disease progression. Recently approved treatments have ...

Learn how stem cells from menstrual blood period blood might help treat Alzheimer’s disease A study shows how they can ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...